Gating Strategy to Data Strategy: Why Manual Workflows Don’t Scale Anymore
For decades, manual gating has been the foundation of flow cytometry analysis. It worked well when panels contained a small number of markers and studies involved manageable datasets.
But flow cytometry has changed.
Modern instruments routinely generate datasets with 20, 30, or even 40+ parameters per cell. Clinical studies may involve hundreds or thousands of samples. At that scale, manual gating is no longer just inefficient — it has become a major limitation in how we analyze and interpret cytometry data.
The problem is not that manual gating is “wrong.” The problem is that it was designed for a much simpler era of cytometry.
Manual Gating Was Built for Smaller Data
Traditional gating workflows rely on sequential 2D plots to identify cell populations. Analysts manually draw boundaries around expected populations and move step-by-step through the dataset.
That approach becomes increasingly difficult as panel complexity grows.
Every additional marker dramatically increases the number of possible marker combinations in the data. A 30-color panel contains far more biological relationships than any human can realistically explore through manual biaxial plots alone.
As a result, most manual workflows simplify the dataset down to a handful of predefined populations. Researchers focus on what they already expect to find while much of the underlying structure in the data remains unexplored.
This creates a major limitation: manual gating is inherently hypothesis-driven. If analysts only search for known populations, unexpected biology can easily be missed.
Recent reviews in high-dimensional cytometry have highlighted this exact issue, noting that traditional 2D gating strategies fail to fully capture the complexity of modern datasets and can limit biological discovery.
The Time Burden Is Becoming Unsustainable
Manual analysis is also extremely time-intensive.
Published estimates suggest that manually analyzing a single high-parameter clinical sample can take roughly 45–90 minutes per file, depending on panel complexity and study design.
That quickly becomes unmanageable in larger studies.
A study with:
- 150 patient samples,
- multiple timepoints,
- and a 30-marker panel
can easily require well over 150 hours of hands-on analysis time before downstream statistics or visualization even begin.
And unlike acquisition workflows, manual analysis does not scale efficiently. More samples simply mean more time spent drawing gates.
This creates bottlenecks across the entire research pipeline:
- slower study completion,
- delayed results,
- analyst fatigue,
- and reduced throughput.
As cytometry datasets continue to grow, human-centered analysis workflows are struggling to keep pace.
Reproducibility Depends Too Much on the Operator
One of the biggest challenges with manual gating is subjectivity.
Two experienced analysts can interpret the same dataset differently. Small differences in gate placement may seem minor, but they can significantly impact downstream population frequencies and biological conclusions.
Studies have reported inter-laboratory variability for manual gating ranging from 17–44%, while other reports show analyst-to-analyst differences of up to 25% in some workflows.
That level of variability becomes a serious issue in clinical research, biomarker discovery, and immuno-oncology studies where reproducibility is critical.
Manual workflows also tend to vary over time. Even the same analyst may gate differently depending on workload, fatigue, or how earlier samples influenced later decisions.
This is why many researchers now describe manual gating as one of the largest sources of variability in flow cytometry analysis.
What Gets Missed in High-Dimensional Data
The biggest limitation of manual gating may not be speed — it may be the biology that never gets discovered.
High-parameter datasets contain far more information than can be visualized through sequential 2D plots. Important signals can remain hidden when analysis is restricted to predefined gates.
These include:
Rare Cell Populations
Rare immune subsets are often difficult to identify manually, especially when they are defined by complex combinations of markers. Automated clustering methods consistently outperform manual workflows in detecting low-frequency populations.
Continuous Cell States
Biological processes like activation, differentiation, and exhaustion rarely occur in neat binary categories. Manual gating forces cells into rigid populations, potentially masking meaningful cellular transitions and gradients.
Unexpected Biology
Manual gating is designed to confirm expected populations. But many important discoveries in modern single-cell biology come from identifying populations researchers were not initially looking for.
If the workflow only searches predefined gates, novel biology may remain invisible.
Moving from Gating to Data Strategy
This does not mean human expertise is no longer important. Experienced cytometrists remain essential for interpreting biology, validating results, and understanding experimental context.
But the role of the analyst is evolving.
Instead of spending hours manually drawing repetitive gates, modern workflows increasingly rely on:
- automated QC pipelines,
- dimensionality reduction tools like UMAP and t-SNE,
- clustering algorithms such as FlowSOM,
- and reproducible scripted analysis pipelines.
These approaches make cytometry analysis:
- faster,
- more scalable,
- more reproducible,
- and better suited for high-dimensional discovery.
The goal is not to replace human expertise. The goal is to allow researchers to spend less time manually navigating plots and more time interpreting biology.
Conclusion
Flow cytometry has entered a new era of scale and complexity.
Manual gating remains useful for validating known populations, but it no longer scales as the primary framework for analyzing modern high-parameter datasets. It is too slow, too variable, and too limited in its ability to capture the full richness of single-cell data.
The field is shifting from a gating-centered workflow to a data-centered workflow — one built around reproducibility, scalability, and discovery.
Labs that make this transition will not just analyze data faster. They will uncover biology that traditional workflows were never designed to see.
References
- Brinkman RR, et al. Improving the Rigor and Reproducibility of Flow Cytometry–Based Clinical Research and Trials Through Automated Data Analysis. Cytometry Part A. 2019.
- Laskowski MK, et al. Rigor and Reproducibility of Cytometry Practices for Immuno-Oncology: A Multifaceted Challenge. Cytometry Part A. 2020.
- Weber LM, et al. diffcyt: differential discovery in high-dimensional cytometry via high-resolution clustering. Communications Biology. 2019.
- den Braanker H, et al. How to Prepare Spectral Flow Cytometry Datasets for High Dimensional Data Analysis: A Practical Workflow. Frontiers in Immunology. 2021.
- Conrad VK, et al. Implementation and Validation of an Automated Flow Cytometry Analysis Pipeline for Human Immune Profiling. Cytometry Part A. 2020.
- Bonaguro L, et al. Unveiling the power of high-dimensional cytometry data with cyCONDOR. Nature Communications. 2024.
- Chorghay Z. Can Clinical Flow Cytometry Gating Analysis Be Automated? Today’s Clinical Lab. 2023.